Home

China

World

Politics

Business

Sci-Tech

Health

Opinions

Video

Live

Radio

World Asia-Pacific Middle East Europe Americas Africa

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

CGTN sits down with Yin Ye, CEO of BGI Group, to explore how breaking cross-industry barriers and leveraging AI are driving a genuine paradigm shift in life sciences. As technology drives the transition from "one-size-fits-all" to personalized medicine, China's proactive, "prevention-first" philosophy is going global. Shifting the gateway from treatment to early screening is not only central to the Healthy China 2030 vision, but also a crucial, unavoidable roadmap for the world to tackle the challenge of an aging society.

06:40

Executive producer: Zhang Jingwen

Producer: Yang Sha

Journalist and editor: Zhang Yuying

Copy editors: Wang Dewei, John Goodrich

Cameramen: Guo Wei, Ren Zhong'an, Zhang Shizhe

Cover: Li Yueyun

Open in CGTN APP for better experience

Search Trends

From treatment to prevention: BGI CEO on the Healthy China 2030 vision